145 related articles for article (PubMed ID: 16236078)
1. The management of lichen planus with low-molecular-weight heparin (enoxaparin).
Akdeniz S; Harman M; Atmaca S; Yaldiz M
Int J Clin Pract; 2005 Nov; 59(11):1268-71. PubMed ID: 16236078
[TBL] [Abstract][Full Text] [Related]
2. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report.
Hodak E; Yosipovitch G; David M; Ingber A; Chorev L; Lider O; Cahalon L; Cohen IR
J Am Acad Dermatol; 1998 Apr; 38(4):564-8. PubMed ID: 9555795
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of lichen planus with low-molecular-weight heparin: a case series of seven patients.
Pacheco H; Kerdel F
J Dermatolog Treat; 2001 Jun; 12(2):123-6. PubMed ID: 12243672
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of lichen planus with sulfasalazine in 20 patients.
Bauzá A; España A; Gil P; Lloret P; Vázquez Doval FJ
Int J Dermatol; 2005 Feb; 44(2):158-62. PubMed ID: 15689219
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus.
Stefanidou MP; Ioannidou DJ; Panayiotides JG; Tosca AD
Br J Dermatol; 1999 Dec; 141(6):1040-5. PubMed ID: 10606849
[TBL] [Abstract][Full Text] [Related]
6. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
7. Oral metronidazole treatment of lichen planus.
Büyük AY; Kavala M
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):260-2. PubMed ID: 10906648
[TBL] [Abstract][Full Text] [Related]
8. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
Tetri S; Hakala J; Juvela S; Saloheimo P; Pyhtinen J; Rusanen H; Savolainen ER; Hillbom M
Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
[TBL] [Abstract][Full Text] [Related]
11. Sodium enoxaparin treatment of sensorineural hearing loss: an immune-mediated response?
Mora R; Jankowska B; Passali GC; Mora F; Passali FM; Crippa B; Quaranta N; Barbieri M
Int Tinnitus J; 2005; 11(1):38-42. PubMed ID: 16419687
[TBL] [Abstract][Full Text] [Related]
12. The successful treatment of palmoplantar hyperkeratotic lichen planus with enoxaparin.
Yasar S; Serdar ZA; Goktay F; Doner N; Tanzer C; Akkaya D; Gunes P
Indian J Dermatol Venereol Leprol; 2011; 77(1):64-6. PubMed ID: 21220884
[No Abstract] [Full Text] [Related]
13. Low-dose low-molecular-weight heparin in lichen planus.
Rai R; Kaur I; Kumar B
J Am Acad Dermatol; 2002 Jan; 46(1):141-3. PubMed ID: 11756963
[No Abstract] [Full Text] [Related]
14. The use of sodium enoxaparin in the treatment of tinnitus.
Mora R; Salami A; Barbieri M; Mora F; Passali GC; Capobianco S; Magnan J
Int Tinnitus J; 2003; 9(2):109-11. PubMed ID: 15106284
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
17. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)].
Tablov B; Ruseva A; Tablov V; Popov I; Stoĭkov S
Akush Ginekol (Sofiia); 2005; 44(5):31-4. PubMed ID: 16313051
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe cutaneous ulcerative lichen planus with low molecular weight heparin in a patient with hepatitis C.
Neville JA; Hancox JG; Williford PM; Yosipovitch G
Cutis; 2007 Jan; 79(1):37-40. PubMed ID: 17330620
[TBL] [Abstract][Full Text] [Related]
19. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral metronidazole in treatment of cutaneous and mucosal lichen planus.
Rasi A; Behzadi AH; Davoudi S; Rafizadeh P; Honarbakhsh Y; Mehran M; Piran P; Dehghan N
J Drugs Dermatol; 2010 Oct; 9(10):1186-90. PubMed ID: 20941941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
